|
タナベ ケンジ
TANABE Kenji
田邊 賢司 所属 研究施設 研究施設 職種 准教授 |
|
| Article types | Review article |
| Language | English |
| Peer review | Peer reviewed |
| Presence of invitation | Invited paper |
| Title | Microtubule Depolymerization by Kinase Inhibitors: Unexpected Findings of Dual Inhibitors. |
| Journal | Formal name：International journal of molecular sciences Abbreviation：Int J Mol Sci ISSN code：(1422-0067)1422-0067(Linking) |
| Domestic / Foregin | Foregin |
| Volume, Issue, Page | 18(12),pp.2508 |
| Author and coauthor | Tanabe Kenji |
| Authorship | Lead author,Corresponding author |
| Publication date | 2017/11 |
| Summary | Microtubule-targeting agents are widely used as clinical drugs in the treatment of cancer. However, some kinase inhibitors can also disrupt microtubule organization by directly binding to tubulin. These unexpected effects may result in a plethora of harmful events and/or a misinterpretation of the experimental results. Thus, further studies are needed to understand these dual inhibitors. In this review, I discuss the roles of dual inhibitors of kinase activity and microtubule function as well as describe the properties underlining their dual roles. Since both kinase and microtubule inhibitors cause cell toxicity and cell cycle arrest, it is difficult to determine which inhibitor is responsible for each phenotype. A discrimination of cell cycle arrest at G0/G1 or G2/M and/or image analyses of cellular phenotype may eventually lead to new insights on drug duality. Because of the indispensable roles of microtubules in mitosis and vesicle transport, I propose a simple and easy method to identify microtubule depolymerizing compounds. |
| DOI | 10.3390/ijms18122508 |
| PMID | 29168788 |